tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (DE:2CL)
FRANKFURT:2CL
Germany Market

BridgeBio Pharma (2CL) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
BridgeBio Pharma Inc’s (2CL) Moving Averages Convergence Divergence (MACD) indicator is 1.31, suggesting BridgeBio Pharma Inc is a Sell.
BridgeBio Pharma Inc’s (2CL) 20-Day exponential moving average is 33.55, while BridgeBio Pharma Inc’s (2CL) share price is €36.47, making it a Buy.
BridgeBio Pharma Inc’s (2CL) 50-Day exponential moving average is 32.14, while BridgeBio Pharma Inc’s (2CL) share price is €36.47, making it a Buy.

BridgeBio Pharma (2CL) Pivot Points

Jun 27, 2025, 05:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
35.76
35.81
35.89
35.94
36.02
36.07
36.15
Fibonacci
35.81
35.86
35.89
35.94
35.99
36.02
36.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BridgeBio Pharma (2CL) Moving Averages

Jun 27, 2025, 05:52 AM
Period
Simple
Exponential
MA5
35.15Buy
35.42Buy
MA10
34.68Buy
34.68Buy
MA20
33.08Buy
33.55Buy
MA50
31.57Buy
32.14Buy
MA100
31.42Buy
31.07Buy
MA200
28.55Buy
28.59Buy
BridgeBio Pharma Inc’s (2CL) 10-Day exponential moving average is 34.68, while BridgeBio Pharma Inc’s (2CL) share price is €36.47, making it a Buy.
BridgeBio Pharma Inc’s (2CL) 100-Day exponential moving average is 31.07, while BridgeBio Pharma Inc’s (2CL) share price is €36.47, making it a Buy.
BridgeBio Pharma Inc’s (2CL) stock price is €36.47 and BridgeBio Pharma Inc’s (2CL) 50-day simple moving average is 31.57, creating a Buy signal.
BridgeBio Pharma Inc’s (2CL) stock price is €36.47 and BridgeBio Pharma Inc’s (2CL) 100-day simple moving average is 31.42, creating a Buy signal.
BridgeBio Pharma Inc’s (2CL) stock price is €36.47 and BridgeBio Pharma Inc’s (2CL) 200-day simple moving average is 28.55, creating a Buy signal.

BridgeBio Pharma (2CL) Technical Indicators

Jun 27, 2025, 05:52 AM
Name
Value
Implied Action
RSI (14)
71.61
Sell
STOCH (9,6)
83.53
Sell
STOCHRSI (14)
93.82
Sell
MACD (12,26)
1.31
Sell
ADX (14)
25.87
Neutral
Williams %R
0.00
Sell
CCI (14)
129.64
Sell
ATR (14)
0.65
-
Ultimate Oscillator
77.70
Buy
ROC
11.53
Buy
BridgeBio Pharma Inc’s (2CL) Relative Strength Index (RSI) is 71.61, creating a Sell signal.
BridgeBio Pharma Inc’s (2CL) Trend Strength Indicator (ADX) is 25.87, creating a Neutral signal.
BridgeBio Pharma Inc’s (2CL) Commodity Channel Index (CCI) is 129.64, creating a Sell signal.
BridgeBio Pharma Inc’s (2CL) Price Rate of Change (ROC) is 11.53, creating a Buy signal.

FAQ

Is 2CL a Buy, Hold, or Sell?
Based on 2CL’s technical indicators, 2CL is a Buy.
    What is 2CL’s RSI (14)?
    2CL’s RSI (14) is 71.61, which suggests 2CL is a Sell.
      What is 2CL’s MACD?
      2CL’s MACD is 1.31, which suggests 2CL is a Sell.
        What is 2CL’s 5-day moving average?
        2CL’s 5-day moving average is 35.15, which suggests 2CL is a Buy.
          What is 2CL’s 20-day moving average?
          2CL 20-day moving average is 33.08, which suggests 2CL is a Buy.
            What is 2CL’s 50-day moving average?
            2CL’s 50-day moving average is 31.57, which suggests 2CL is a Buy.
              What is 2CL’s 200-day moving average?
              2CL’s 200-day moving average is 28.55, which suggests 2CL is a Buy.
                What is 2CL’s Williams % R (14)?
                2CL’s Williams % R (14) is 0.00, which suggests 2CL is a Sell.
                  What is 2CL’s CCI (14)?
                  2CL’s CCI (14) is 129.64, which suggests 2CL is a Sell.
                    What is the share price of BridgeBio Pharma Inc?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis